TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -3 | -19 | 2 | -19 | -73 | -19 |
| P | %wins | 0 | 0 | 0 | 100 | 0 | 0 | 17 | |||
| S | %ret | 2 | 1 | 13 | 1 | -6 | -11 | -24 | -51 | -76 | -28 |
| S | %wins | 77 | 69 | 92 | 85 | 100 | 100 | 87 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/11 10:38 | 8/9/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -340 | 2.08 | 0 | -163 | -100 | 0 | I | -77 | -71 | -65 | -40 | -2 | 6 | -24 | -26 | 17 | 2 | -6 | -27 | -54 | |
6/28/11 08:54 | 6/24/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -18 | 2.10 | 1 | -9 | -5 | 163 | I | -67 | -72 | -70 | -49 | -28 | -4 | -22 | 14 | -4 | -17 | -1 | -25 | -50 | |
6/27/11 08:33 | 6/23/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -105 | 2.09 | 1 | -50 | -23 | 172 | I | -64 | -72 | -71 | -51 | -29 | -5 | -26 | 13 | 0 | -14 | -12 | -21 | -54 | |
6/23/11 13:07 | 6/16/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.a | -1,253 | 3.14 | 0 | -399 | -51 | 385 | I | -70 | -78 | -75 | -56 | -41 | -26 | 7 | -16 | 18 | 3 | -3 | -4 | -49 | |
6/20/11 07:57 | 6/16/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -1,253 | 3.14 | 0 | -399 | -61 | 255 | I | -69 | -75 | -69 | -40 | -32 | -19 | 4 | 28 | -9 | -4 | -20 | -23 | -52 | |
6/6/11 08:19 | 6/2/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -49 | 2.34 | 0 | -21 | -7 | 262 | I | -64 | -70 | -61 | -40 | -33 | -21 | -11 | -15 | -5 | -20 | -25 | -21 | -54 | |
6/2/11 09:52 | 6/1/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -27 | 2.46 | 0 | -11 | -4 | 283 | I | -60 | -69 | -55 | -29 | -24 | -18 | -10 | -7 | -2 | -17 | -27 | -26 | -60 | |
3/30/11 09:50 | 3/28/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -50 | 4.07 | 0 | -12 | -4 | 294 | I | 22 | -60 | -42 | -40 | -20 | 2 | 10 | -5 | 5 | 2 | -10 | -50 | -69 | |
3/28/11 12:05 | 3/24/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -616 | 4.03 | 0 | -153 | -23 | 522 | I | 18 | -56 | -39 | -42 | -20 | 7 | 26 | 7 | -3 | -3 | -14 | -51 | -61 | |
3/25/11 18:03 | 3/23/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -135 | 4.01 | 0 | -34 | -3 | 981 | I | 24 | -58 | -39 | -42 | -20 | 9 | 19 | 8 | -3 | 0 | -13 | -50 | -61 | |
3/2/11 11:26 | 2/28/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -52 | 3.67 | 0 | -14 | -4 | 328 | I | 194 | -55 | -40 | -39 | -41 | -31 | -16 | -10 | -3 | 4 | 15 | -26 | -47 | -83 |
8/16/10 06:47 | 7/12/10 | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -83 | 4.15 | 1 | -20 | -3 | 572 | I | -52 | -38 | -21 | -25 | 20 | 2 | -9 | -6 | -1 | -6 | -6 | 11 | -34 | -73 |
7/29/10 11:23 | 12/3/09 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | P.m | 1,622 | 7.77 | 0 | 209 | 25 | 1,029 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:20 | 9/11/09 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | P.m | 3,621 | 8.34 | 0 | 434 | 113 | 820 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:20 | 11/11/09 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -220 | 8.32 | 0 | -26 | -3 | 820 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |